7th Annual ECD Medical Symposium Milan, Italy
Milan Simposio Médico Group Picture 2019
Symposium Summary
Approximately 38 medical professionals from nine countries attended the Annual ECD Simposio Médico in 2019. Twelve oral abstracts were presented, along with an additional four poster presentations. As an invited speaker, Prof. Luigi Naldini, delivered a talk titled “Genetic engineering of hematopoiesis to treat
inherited diseases and cancer.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.
Experiencias de los asistentes
“ECDGA provides important recursos for my patients that has led to faster diagnóstico. It also provides a community for patients with a rare disease to feel less alone.”
– Mark Heaney, MD, 2019 Attendee
Programs with Symposium Agenda
Presentaciones
| Presentador | Diapositivas de la presentación | English Video |
|---|---|---|
| Jithma P. Abeykoon, MD | Histopathologic Mimics of Erdheim-Chester Disease | No Vídeos available |
| Benjamin H. Durham | Novel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation | No Vídeos available |
| Marina Ferrarini, MD | Novel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation | No Vídeos available |
| Filip Janku, MD, PhD | MEK inhibition with trametinib in patients with non-Langerhans cell histiocytosis irrespective of BRAF mutation status | No Vídeos available |
| Francesco Pegoraro, MD | Erdheim-Chester with multiple lesions related to BRAF V600E mutation. A simple coincidence? | No Vídeos available |
| Julien Haroche, doctor en Medicina y doctor en Filosofía | PD-1/PD-L1 expression is frequent and correlates with inflammation in Erdheim-Chester disease | No Vídeos available |
| Rikhia Chakraborty, MD | Targeted inhibition of the MAPK pathway in combination with immune checkpoint inhibitors restores immune dysfunction ex vivo and reduces disease burden in a mouse model of Langerhans cell histiocytosis | No Vídeos available |
| Simonetta Gerevini, MD | CNS imaging in ECD Workshop | No Vídeos available |
| Claudio Doglioni, MD | State of the Art of ECD Pathology Workshop | No Vídeos available |
| Antonio Esposito, MD | Cardiac Imaging in ECD Workshop | No Vídeos available |
| Kazuhiro Toyama, MD | Prognostic factors of Erdheim–Chester Disease: A nationwide survey in Japan | No Vídeos available |
| Eli L. Diamond, MD | Phase 2 Trial of Cobimetinib for Adults with Histiocytosis: Results in BRAFV600-wildtype and BRAFV600E-mutated patients | No Vídeos available |
| Roei Mazor, MD | Diagnostic & Therapeutic Challenges of Mixed Histiocytosis in the Era of Precision Medicine | No Vídeos available |
| Kathy Brewer and Lorenzo Dagna, MD | Closing | No Vídeos available |
Fotografías
Reception
